These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8848890)

  • 1. Reversal of atracurium-induced neuromuscular block in paediatric patients.
    Kirkegaard-Nielsen H; Meretoja OA; Wirtavuori K
    Acta Anaesthesiol Scand; 1995 Oct; 39(7):906-11. PubMed ID: 8848890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neostigmine and edrophonium as antagonists of atracurium and pancuronium.
    Sanfilippo M; Vilardi V; Fierro G; Rosa G; Pelaia P; Gasparetto A
    Acta Anaesthesiol Scand; 1988 Aug; 32(6):437-40. PubMed ID: 2845694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of edrophonium and neostigmine for the antagonism of atracurium-induced neuromuscular block.
    Lavery GG; Mirakhur RK; Gibson FM
    Anesth Analg; 1985 Sep; 64(9):867-70. PubMed ID: 3161421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Bülow K
    J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response relationships for edrophonium and neostigmine antagonism of atracurium and cisatracurium-induced neuromuscular block.
    Naguib M; Riad W
    Can J Anaesth; 2000 Nov; 47(11):1074-81. PubMed ID: 11097536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of intense atracurium-induced neuromuscular block in children.
    Gwinnutt CL; Walker RW; Meakin G
    Br J Anaesth; 1991 Jul; 67(1):13-6. PubMed ID: 1859751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery characteristics following antagonism of atracurium with neostigmine or edrophonium.
    Jones RM; Pearce AC; Williams JP
    Br J Anaesth; 1984 May; 56(5):453-7. PubMed ID: 6326785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-response relationships for edrophonium and neostigmine as antagonists of atracurium and vecuronium neuromuscular blockade.
    Smith CE; Donati F; Bevan DR
    Anesthesiology; 1989 Jul; 71(1):37-43. PubMed ID: 2568767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atracurium after an anticholinesterase. Does prior reversal with edrophonium or neostigmine influence the response to atracurium?
    Shorten GD; Ali HA
    Anaesthesia; 1993 Jun; 48(6):524-6. PubMed ID: 8322995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response relationships for edrophonium and neostigmine as antagonists of moderate and profound atracurium blockade.
    Donati F; Smith CE; Bevan DR
    Anesth Analg; 1989 Jan; 68(1):13-9. PubMed ID: 2910133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
    Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
    Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of vecuronium and atracurium: comparison of neostigmine and edrophonium administered at 5% twitch height recovery.
    Caldwell JE; Robertson EN; Baird WL
    Br J Anaesth; 1987 Apr; 59(4):478-81. PubMed ID: 2882769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priming reversal of profound atracurium blockade by edrophonium and neostigmine.
    Liu CH; Lin IS; Liu CG; Peng TH; Yeh YJ; Chuu LJ; Lin SY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1995 May; 11(5):257-64. PubMed ID: 7602663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
    Naguib M; Abdulatif M; al-Ghamdi A
    Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of atracurium-induced block in obese patients.
    Kirkegaard-Nielsen H; Lindholm P; Petersen HS; Severinsen IK
    Can J Anaesth; 1998 Jan; 45(1):39-41. PubMed ID: 9466025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
    Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
    Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neostigmine and edrophonium antagonism of varying intensity neuromuscular blockade induced by atracurium, pancuronium, or vecuronium.
    Rupp SM; McChristian JW; Miller RD; Taboada JA; Cronnelly R
    Anesthesiology; 1986 Jun; 64(6):711-7. PubMed ID: 2872839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H; Helbo-Hansen HS; Lindholm P; Severinsen IK; Pedersen HS; Jensen EW
    Can J Anaesth; 1996 Sep; 43(9):932-8. PubMed ID: 8874911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.